Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: Do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up
Debabrata Mukherjee, Eric J. Topol, Michel E. Bertrand, Steen D. Kristensen, Howard C. Herrmann, Franz Josef Neumann, Steven J. Yakubov, Jean Pierre Bassand, Rick R. McClure, Gregg W. Stone, Diego Ardissino, David J. Moliterno
Research output: Contribution to journal › Article › peer-review
24Scopus
citations
Fingerprint
Dive into the research topics of 'Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: Do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up'. Together they form a unique fingerprint.